Envista Holdings Corp (NVST)
Automate Your Wheel Strategy on NVST
With Tiblio's Option Bot, you can configure your own wheel strategy including NVST - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NVST
- Rev/Share 16.542
- Book/Share 18.8948
- PB 1.5338
- Debt/Equity 0.5499
- CurrentRatio 2.377
- ROIC 0.0126
- MktCap 4765072725.0
- FreeCF/Share 1.4015
- PFCF 20.6817
- PE 101.3683
- Debt/Assets 0.3008
- DivYield 0
- ROE 0.0152
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | NVST | Leerink Partners | Market Perform | Outperform | -- | $35 | Feb. 6, 2026 |
| Initiation | NVST | Barclays | -- | Overweight | -- | $24 | Dec. 9, 2025 |
| Upgrade | NVST | Robert W. Baird | Neutral | Outperform | -- | $23 | May 27, 2025 |
| Initiation | NVST | Mizuho | -- | Underperform | -- | $20 | Dec. 4, 2024 |
| Initiation | NVST | Wells Fargo | -- | Equal Weight | -- | $20 | Oct. 8, 2024 |
News
Why Envista (NVST) is a Top Value Stock for the Long-Term
Published: February 24, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
NVST or ESLOY: Which Is the Better Value Stock Right Now?
Published: February 18, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down
Published: February 12, 2026 by: Zacks Investment Research
Sentiment: Positive
NVST shares jump 22% after Q4 EPS and revenue beat, with profits up 58% and double-digit segment growth despite gross margin pressure.
Read More
3 Stocks With Upgraded Broker Ratings to Buy Amid AI-Related Headwinds
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
Broker upgrades make J, NVST and TPR top picks amid an AI-driven sell-off as markets demand clearer AI monetization and disciplined spending.
Read More
Here's Why Envista (NVST) is a Strong Growth Stock
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Surging Earnings Estimates Signal Upside for Envista (NVST) Stock
Published: February 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
Envista (NVST) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: February 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Here's Why Envista (NVST) is a Strong Momentum Stock
Published: February 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Envista Holdings Corporation (NVST) Hit a 52 Week High, Can the Run Continue?
Published: February 09, 2026 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Envista Holdings Corporation (NVST) Q4 2025 Earnings Call Transcript
Published: February 06, 2026 by: Seeking Alpha
Sentiment: Neutral
Envista Holdings Corporation (NVST) Q4 2025 Earnings Call Transcript
Read More
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
NVST or ABT: Which Is the Better Value Stock Right Now?
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
NVST vs. SYK: Which Stock Is the Better Value Option?
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Read More
NVST vs. SYK: Which Stock Should Value Investors Buy Now?
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Here's Why Envista (NVST) is a Strong Momentum Stock
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Published: October 31, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Envista (NVST) Earnings Expected to Grow: Should You Buy?
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Will Envista (NVST) Beat Estimates Again in Its Next Earnings Report?
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
NVST or ABT: Which Is the Better Value Stock Right Now?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Read More
Here's Why Envista (NVST) is a Strong Value Stock
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
NVST vs. ABT: Which Stock Is the Better Value Option?
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Why Envista (NVST) is a Top Value Stock for the Long-Term
Published: September 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
Read More
NVST vs. ABT: Which Stock Should Value Investors Buy Now?
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Read More
Envista (NVST) Upgraded to Strong Buy: Here's Why
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
4 Stocks Trading Near 52-Week High With Room to Rise Further
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors target stocks that have been on a bullish run. Stocks like POST, MD, NVST and ZION are seeing price strength, and the momentum is likely to continue.
Read More
NVST or ABT: Which Is the Better Value Stock Right Now?
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
4 Medical Product Stocks to Watch From a Challenging Industry
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Negative
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like FHI, NVST, COMM and FLS are seeing price strength and have a high chance of carrying the momentum forward.
Read More
Earnings Estimates Moving Higher for Envista (NVST): Time to Buy?
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
About Envista Holdings Corp (NVST)
- IPO Date 2019-09-18
- Website http://www.envistaco.com
- Industry Medical - Equipment & Services
- CEO Paul A. Keel
- Employees 12300